These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16770537)

  • 21. Angiogenesis inhibitors in the treatment of lung cancer.
    Sun S; Schiller JH
    Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecularly targeted therapy for melanoma: current reality and future options.
    Becker JC; Kirkwood JM; Agarwala SS; Dummer R; Schrama D; Hauschild A
    Cancer; 2006 Nov; 107(10):2317-27. PubMed ID: 17039502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current chemo- and hormone therapy in disseminated malignant melanoma of the skin].
    Akimov MA; Gershanovich ML
    Vopr Onkol; 1999; 45(4):341-9. PubMed ID: 10532089
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy and targeted therapy combinations in advanced melanoma.
    Flaherty KT
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2366s-2370s. PubMed ID: 16609060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting growth factors and angiogenesis; using small molecules in malignancy.
    Wanebo HJ; Argiris A; Bergsland E; Agarwala S; Rugo H
    Cancer Metastasis Rev; 2006 Jun; 25(2):279-92. PubMed ID: 16770540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel therapeutics for melanoma.
    Seetharamu N; Ott PA; Pavlick AC
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):839-49. PubMed ID: 19496721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of metastatic melanoma 2005.
    O'Day S; Boasberg P
    Surg Oncol Clin N Am; 2006 Apr; 15(2):419-37. PubMed ID: 16632224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytokine-based and targeted therapy of metastatic renal cell carcinoma--a current analysis].
    Johannsen M; Ringsdorf M; Römer A; Loening SA; Roigas J
    Aktuelle Urol; 2007 Jan; 38(1):38-45. PubMed ID: 17290328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reaching first base in the treatment of metastatic melanoma.
    Eggermont AM
    J Clin Oncol; 2006 Oct; 24(29):4673-4. PubMed ID: 16966683
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of interleukins for advanced melanoma.
    Miller SJ
    Skin Therapy Lett; 2001; 6(4):3-5. PubMed ID: 11176044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging therapies for melanoma.
    Katipamula R; Markovic SN
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant melanoma.
    Schwartsmann G; Parkinson DR
    Cancer Chemother Biol Response Modif; 1993; 14():577-93. PubMed ID: 8312120
    [No Abstract]   [Full Text] [Related]  

  • 33. Has first-line therapy had an impact on general outcome in metastatic breast cancer?
    McArthur HL; Hudis CA
    Future Oncol; 2007 Aug; 3(4):411-8. PubMed ID: 17661716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope.
    Deshpande HA; Gettinger SN; Sosa JA
    Curr Opin Oncol; 2008 Jan; 20(1):19-24. PubMed ID: 18043252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense strategies for oncogene inactivation.
    Stein CA; Benimetskaya L; Mani S
    Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA; Wilhelm S; Carter C; Kelley SL
    Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
    Bedikian AY; Millward M; Pehamberger H; Conry R; Gore M; Trefzer U; Pavlick AC; DeConti R; Hersh EM; Hersey P; Kirkwood JM; Haluska FG;
    J Clin Oncol; 2006 Oct; 24(29):4738-45. PubMed ID: 16966688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapy for uveal melanoma.
    Triozzi PL; Eng C; Singh AD
    Cancer Treat Rev; 2008 May; 34(3):247-58. PubMed ID: 18226859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translational research in melanoma.
    Tsai S; Sabel MS
    Surg Oncol Clin N Am; 2008 Apr; 17(2):391-419, ix-x. PubMed ID: 18375359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.